The Ebola outbreak in the Democratic Republic of Congo is being driven by the Bundibugyo strain, a less familiar cousin of the virus that has complicated every aspect of the response. Understanding the virology is essential to understanding why this outbreak, now spread to eight provinces with around 9,415 cases and 4,536 deaths, has proven so difficult to contain.
Ebolaviruses come in several species, and they are not interchangeable. The Zaire species, responsible for the devastating West African epidemic of 2014-2016, is the best studied and the target of licensed vaccines. Bundibugyo, first identified in Uganda in 2007, is genetically distinct enough that Zaire-targeted vaccines may offer limited protection, forcing responders to lean on the older tools of outbreak control.
How it spreads, how it kills
Ebola spreads through direct contact with the bodily fluids of an infected person or animal, blood, vomit, sweat, semen. It is not airborne, which is both reassuring and the reason containment works: break the chains of contact and the outbreak starves. The virus attacks the vascular system, causing fever, vomiting, diarrhoea and in severe cases uncontrolled bleeding. Case fatality rates vary by strain and care quality, but Ebola remains one of the deadliest known pathogens.
The 21-day incubation period is the epidemiologist’s enemy. Infected people can travel far before symptoms appear, which is why the spread to North Ubangi, an eighth province, is so concerning: each new front multiplies the contact-tracing workload.
The science of containment
Modern Ebola response is a triumph of applied science: rapid diagnostics, experimental therapeutics, ring vaccination strategies, and genomic sequencing that tracks transmission chains in near real time. But science needs infrastructure, and eastern Congo’s health system is operating at its limits. Our earlier science coverage explored the outbreak’s trajectory, with more on the public-health science. UN News has the latest official figures.
